NATURE’S SUNSHINE PRODUCTS, INC.

NATR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $19.5M $7.7M $15.1M $-390.0K $30.2M $23.0M $6.9M $-1.2M
Depreciation & Amortization $13.8M $14.2M $11.8M $11.0M $11.2M $10.7M $10.6M $9.8M
Depreciation $13.8M $14.2M $11.8M $11.0M $11.1M $10.4M $10.5M $9.8M
Amortization $100.0K $100.0K
Stock-Based Compensation $5.8M $4.8M $4.9M $2.9M $3.7M $3.8M $2.1M $2.2M
Net Cash from Operating Activities $35.3M $25.3M $41.2M $710.0K $34.6M $37.7M $8.5M $21.8M
Investing Activities
Capital Expenditures $6.5M $11.0M $10.5M $7.6M $6.7M $4.9M $5.1M $4.8M
Business Acquisitions
Net Cash from Investing Activities $-6.5M $-11.0M $-10.5M $-7.6M $-6.6M $-4.9M $-5.1M $211.0K
Financing Activities
Dividends Paid $0 $19.9M $0 $0
Stock Repurchases $16.3M $8.9M $6.4M $13.6M $7.4M $0
Net Cash from Financing Activities $-23.8M $-9.9M $-8.0M $-16.2M $-31.7M $3.9M $-63.0K $-12.2M
Net Change in Cash $9.2M $2.3M $22.3M $-26.2M $-5.9M $38.4M $3.0M $7.7M
Free Cash Flow $28.8M $14.3M $30.7M $-6.9M $27.9M $32.8M $3.4M $17.0M
← Newer Page 1 of 3 Older →